RWD19 Comparative Effectiveness Using External Controls for Single-Arm Trials of Pembrolizumab in Tumor-Agnostic Indications Leveraging Real-World Data
Abstract
Authors
Y. Chen P. Martin S. Ye L. Inoue A. Basu J.J Carlson